THE EVALUATION OF THE PROCALCITONIN LEVELS IN CHRONIC PROSTATITIS PATIENTS

RESEARCH ARTICLE

Nobel Med 2016; 12(2): 60-65

THE EVALUATION OF THE PROCALCITONIN LEVELS IN CHRONIC PROSTATITIS PATIENTS

Basri Çakıroğlu, Erkan Eyyüpoğlu, Mustafa Bahadır Can Balcı, Aydın İsmet Hazar, Bekir Sami Uyanık, Akif Nuri Doğan

ABSTRACT

Objective: To explore the relationship between procalcitonin levels and non-bacterial chronic prostatitis and its place in follow ups.
Material and Method: From January, 2014 to August, 2014, 53 patients with symptomatic chronic prostatitis were included in this study. Before and after treatment, the United States National Institutes of Health chronic prostatitis symptom index (NIH-CPSI), pain scores, the International Prostate Symptom Score (IPSS), procalcitonin, leukocyte (WBC), mean platelet volume, hemoglobin (Hb), total prostate-specific antigen (PSA), C-Reactive Protein(CRP) levels, and erythrocyte sedimentation rate (ESR) were evaluated prospectively.
Results: In 47 of the 53 patients (89%) who participated in the study, the procalcitonin levels in the serum were over the threshold value of 0.05 ng/ml. After the treatment, 29 of these 47 patients beginning with high procalcitonin levels (62%) were found to have levels lower than the threshold value of 0.05 ng/ml. In which 18 patients with procalcitonin levels below the threshold, significant decreases in the levels (0.069±0.014, 0.053±0.005, p<0.001) were noted. In 6 patients who had chronic prostatitis with an initial value lower than the threshold, the value remained lower than 0.05 ng/ml.
Conclusion: Because chronic prostatitis is a recurring chronic disease, the detection of relapses, finding antibiotic treatment options, and determination of procalcitonin levels may be of importance. Further studies will improve our understanding of the chronic prostatitis dilemma.

Keywords

Chronic prostatitis Procalcitonin Mean platelet volume

Article Details

Download Full Text in PDF Format Read Full Text Other Articles in This Issue

EPILEPSY MANAGEMENT AT WORK ENVIRONMENT: ASPECTS OF OCCUPATIONAL HEALTH AND SAFETY

05-12

Sibel Cevizci, Ethem Erginöz, Handan Işın Özışık Karaman

REVIEW Nobel Med 2016; 12(2): 5-12

MULTIPLE PRIMARY MALIGNANT NEOPLASMS FROM EASTERN BLACK SEA REGION OF TURKEY: SINGLE CENTER EXPERIENCE

13-19

Zümrüt Bahat, Mustafa Kandaz, Yahyahan Memiş, Emine Canyılmaz, Halil Kavgacı, Adnan Yöney

RESEARCH ARTICLE Nobel Med 2016; 12(2): 13-19

RISK OF DEVELOPING SUBCLINICAL HYPOTHYROIDISM AMONG INDIVIDUALS WITH TSH VALUES 2.5-4.2 mIU/L

20-25

Tülay Çevlik, Goncagül Haklar, Önder Şirikçi, Kaya Emerk

RESEARCH ARTICLE Nobel Med 2016; 12(2): 20-25

ASSOCIATION BETWEEN MIGRAINE AND ALLERGIC RHINITIS IN CHILDHOOD AND ADOLESCENCE

26-30

Serhat Güler, Erdal Sakallı, Gözde Yeşil

RESEARCH ARTICLE Nobel Med 2016; 12(2): 26-30

ACUPUNCTURE FOR THE TREATMENT OF MILD OR MODERATE ASTHMA: A RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

31-37

Gülden Bilgin, Hüseyin Arslan, Nurgül Balcı, Didem Sunay

RESEARCH ARTICLE Nobel Med 2016; 12(2): 31-37

THE IMPACT OF hsCRP LEVELS ACROSS GLUCOSE TOLERANCE CATEGORIES: FROM NORMAL GLUCOSE TOLERANCE TO ESTABLISHED DIABETES

38-44

Yıldız Tütüncü, İlhan Satman, Selda Çelik, Bülent Canbaz, Fulya Türker, Nevin Dinççağ, Kubilay Karşıdağ, Ayşegül Telci, Sema Genç, Beyhan Ömer

RESEARCH ARTICLE Nobel Med 2016; 12(2): 38-44

AN ESTIMATION OF IMPAIRED FASTING GLUCOSE PREVALENCE AND RELATED FACTORS: A MIDDLE SCHOOL-BASED STUDY IN CHILDREN AGED 9-16 YEARS

45-52

Sevil İkinci, Seher Nazlı Atak, Ali Rıza Uysal, Serdal Kenan Köse

RESEARCH ARTICLE Nobel Med 2016; 12(2): 45-52

FASTING AND FED BIOEQUIVALENCE STUDIES OF ETODOLAC SUSTAINED RELEASE TABLETS MANUFACTURED IN TURKEY IN HEALTHY VOLUNTEERS

53-59

Abdullah Uslu, İlksen Dikmen, Seda Ünsalan, Berrak Kılınç, Onursal Sağlam, Aydın Erenmemişoğlu, İclal Çakıcı, Ömer Ocak

RESEARCH ARTICLE Nobel Med 2016; 12(2): 53-59

THE EVALUATION OF THE PROCALCITONIN LEVELS IN CHRONIC PROSTATITIS PATIENTS

60-65

Basri Çakıroğlu, Erkan Eyyüpoğlu, Mustafa Bahadır Can Balcı, Aydın İsmet Hazar, Bekir Sami Uyanık, Akif Nuri Doğan

RESEARCH ARTICLE Nobel Med 2016; 12(2): 60-65

INTERFERENCE ON HbA1C MEASUREMENT BY HPLC: HB D

66-68

Mehmet Kalaycı, Hakan Ayyıldız, Mahmut Bozkurt, Mustafa Timurkaan

REPORT Nobel Med 2016; 12(2): 66-68

LONG TERM FOLLOW-UP OF FIVE PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA, CASE BASED CLINICAL STUDY

69-74

Gülbüz Sezgin

REPORT Nobel Med 2016; 12(2): 69-74

ANESTHETIC MANAGEMENT FOR IMPLANTATION OF TOTAL ARTIFICIAL HEART DEVICE: CASE SERIES

75-79

Cengiz Sahutoğlu, Nursen Karaca, Seden Kocabaş, Fatma Zekiye Askar, Serkan Ertugay, Çağatay Engin, Tahir Yağdı, Mustafa Özbaran

REPORT Nobel Med 2016; 12(2): 75-79

A MACULOPAPULAR AND PUSTULAR RASH FOLLOWED BY ERYTHEMA MULTIFORME IN A PATIENT TREATED WITH HYDROXYCHLOROQUINE

80-82

Hatice Duman, İlteris Oğuz Topal, Kübra Cüre, Emek Kocatürk, Çağlar Çakır

REPORT Nobel Med 2016; 12(2): 80-82

RUPTURED HEPATIC ARTERY ANEURYSMS IN THE SETTING OF POLYARTERITIS NODOSA: BUYING TIME WITH ENDOVASCULAR EMBOLIZATION

83-86

Derya Türeli, İsmet Cengiç, Nazila Arasteh, Fikret Küçükkaya, Feyyaz Baltacıoğlu

REPORT Nobel Med 2016; 12(2): 83-86

ORD. PROF. DR. PHILIPP SCHWARTZ (1894-1977) HIS CONTRIBUTION TO 1933 UNIVERSITY REFORM IN TURKEY AND TO PATHOLOGY

87-90

Arın Namal

A PORTRAIT Nobel Med 2016; 12(2): 87-90

LIVER AND SYSTEMIC DISEASES

05-09

Sebati Özdemir

REVIEW Nobel Med 2013; 9(2): 5-9

AGING KIDNEY: SENESCENCE OR DISEASE?

10-14

Meltem Gürsu, Rümeyza Kazancıoğlu, Savaş Öztürk

REVIEW Nobel Med 2013; 9(2): 10-14

IMPORTANCE OF HOLOTRANSCOBALAMIN (HOLOTC) MEASUREMENTS IN EARLY DIAGNOSIS OF COBALAMIN DEFICIENCY, ESPECIALLY IN PATIENTS WITH BORDERLINE VITAMIN B12 CONCENTRATIONS

15-20

Faruk Sönmezışık, Esma Sürmen Gür, Burak Asıltaş

RESEARCH ARTICLE Nobel Med 2013; 9(2): 15-20

EVALUATION OF PHYSICAL GROWTH IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

21-25

Celalettin Koşan, Oğuzhan Sepetçigil, Atilla Çayır, Avni Kaya, Behzat Özkan

RESEARCH ARTICLE Nobel Med 2013; 9(2): 21-25

COMPARISON OF RISK INDEXES USED IN DETERMINING THE POSTOPERATIVE RESPIRATORY INSUFFICIENCY RISK

26-31

Gülsüm Kavalcı, Cavidan Arar, Alkın Çolak, Nesrin Turan, Cemil Kavalcı

RESEARCH ARTICLE Nobel Med 2013; 9(2): 26-31

THE EVALUATION OF PRENATAL AND ENVIROMENTAL RISK FACTORS IN CHILDREN WITH ASTHMA, ALLERGIC RHINITIS AND BRONCHIAL ASTHMA ABSTRACT

32-37

Mehmet İbrahim Turan, Müferet Ergüven, Mehmet Özdemir

RESEARCH ARTICLE Nobel Med 2013; 9(2): 32-37

REOPERATIONS AND MORBIDITY IN THYROID SURGERY

38-42

Serkan Teksöz, Murat Özcan, Aytül Sargan, Yusuf Bukey, Recep Özgültekin, Ateş Özyeğin

RESEARCH ARTICLE Nobel Med 2013; 9(2): 38-42

EFFECTS OF RAMADAN FASTING ON BLOOD PRESSURE CONTROL, LIPID PROFILE, BRAIN NATRIURETIC PEPTIDE, RENAL FUNCTIONS AND ELECTROLYTE LEVELS IN HYPERTENSIVE PATIENTS TAKING COMBINATION THERAPY

43-46

İbrahim Faruk Aktürk, İsmail Bıyık, Cüneyt Koşaş, Ahmet Arif Yalçın, Mehmet Ertürk, Fatih Uzun

RESEARCH ARTICLE Nobel Med 2013; 9(2): 43-46

MANAGEMENT OF A LARGE OUTBREAK CAUSED BY NOROVIRUS AND CAMPYLOBACTER JEJUNI OCCURRED IN A RURAL AREA IN TURKEY

47-51

İbak Gönen

RESEARCH ARTICLE Nobel Med 2013; 9(2): 47-51

FREQUENT CD99 AND FLI-1 EXPRESSIONS IN DIFFUSE LARGE B-CELL LYMPHOMA AND THEIR ASSOCIATION WITH PROLIFERATIVE AND APOPTOTIC RATES

52-56

Ufuk Berber, İsmail Yılmaz, Tolga Tuncel, Zafer Küçükodacı Aptullah Haholu

RESEARCH ARTICLE Nobel Med 2013; 9(2): 52-56

Pubmed Style
Basri Çakıroğlu, Erkan Eyyüpoğlu, Mustafa Bahadır Can Balcı, Aydın İsmet Hazar, Bekir Sami Uyanık, Akif Nuri Doğan. [THE EVALUATION OF THE PROCALCITONIN LEVELS IN CHRONIC PROSTATITIS PATIENTS]. Nobel Med 2016; 12(2): 60-65, English.
Web Style
Basri Çakıroğlu, Erkan Eyyüpoğlu, Mustafa Bahadır Can Balcı, Aydın İsmet Hazar, Bekir Sami Uyanık, Akif Nuri Doğan. [THE EVALUATION OF THE PROCALCITONIN LEVELS IN CHRONIC PROSTATITIS PATIENTS]. www.nobelmedicus.com/en/Article.aspx?m=1716 [Access: Mayıs 24, 2021], English.
AMA (American Medical Association) Style
Basri Çakıroğlu, Erkan Eyyüpoğlu, Mustafa Bahadır Can Balcı, Aydın İsmet Hazar, Bekir Sami Uyanık, Akif Nuri Doğan. [THE EVALUATION OF THE PROCALCITONIN LEVELS IN CHRONIC PROSTATITIS PATIENTS]. Nobel Med 2016; 12(2): 60-65, English.
Vancouver/ICMJE Style
Basri Çakıroğlu, Erkan Eyyüpoğlu, Mustafa Bahadır Can Balcı, Aydın İsmet Hazar, Bekir Sami Uyanık, Akif Nuri Doğan. [THE EVALUATION OF THE PROCALCITONIN LEVELS IN CHRONIC PROSTATITIS PATIENTS]. Nobel Med (2016); 12(2): 60-65, [cited Mayıs 24, 2021], English.
Harvard Style
Basri Çakıroğlu, Erkan Eyyüpoğlu, Mustafa Bahadır Can Balcı, Aydın İsmet Hazar, Bekir Sami Uyanık, Akif Nuri Doğan. (2016) [THE EVALUATION OF THE PROCALCITONIN LEVELS IN CHRONIC PROSTATITIS PATIENTS]. Nobel Med, 12(2): 60-65, English.